Intrinsic expression of Th2 cytokines in urothelium of congenital ureteropelvic junction obstruction

Kidney International

Volumn 67, Issue 2, 2005, Pages 638-646

  Chiou, Yuan Yow ^b   Shieh, Chi Chang ^b   Cheng, Hong Lin ^b   Tang, Ming Jer ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NONE

Author keywords

Allergy and immunology; Child; Human; Kidney pelvis; Ureteral obstruction

Indexed keywords

CHEMOKINE; CYTOKINE; EOTAXIN; GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 5; KI 67 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FEMALE; HUMAN; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; IMMUNOREGULATION; IN SITU HYBRIDIZATION; INFLAMMATORY CELL; MALE; MAST CELL DEGRANULATION; MONONUCLEAR CELL; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PYELOPLASTY; TH1 CELL; TH2 CELL; URETEROPELVIC JUNCTION OBSTRUCTION; UROTHELIUM;

EID: 12344263729     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.67120.x     Document Type: Article

References (38)

1. PETERS CA: Lower urinary tract obstruction: Clinical and experimental aspects. Br J Urol 81(Suppl 2):22-32, 1998
2. ROTH KS, KOO HP, SPOTTSWOOD SE, et al: Obstructive uropathy: An important cause of chronic renal failure in children. Clin Pediatr (Phila) 41:309-314, 2002
3. KOHAUT EC, TEJANI A: The 1994 annual report of the North American Pediatrie Renal Transplant Cooperative Study. Pediatr Nephrol 10:422-434, 1996
4. DHILLON HK: Prenatally diagnosed hydronephrosis: The Great Ormond Street experience. Br J Urol 81(Suppl 2):39-44, 1998
5. FLASHNER SC, MESROBIAN HG, FLATT JA, et al: Nonobstructive dilatation of upper urinary tract may later convert to obstruction. Urology 42:569-573, 1993
6. HANNA MK, JEFFS RD, STURGESS JM, BARKIN M: Ureteral structure and ultrastructure: Part II. Congenital ureteropelvic junction obstruction and primary obstructive megaureter. J Urol 116:725-730, 1976
7. ZHANG PL, PETERS CA, ROSEN S: Ureteropelvic junction obstruction: Morphological and clinical studies. Pediatr Nephrol 14:820-826, 2000
8. BAUMGART P, MULLER KM, LISON AE: Epithelial abnormalities in the renal pelvis in experimental hydronephrosis and pyelonephritis. Pathol Res Pract 176:185-195, 1983
9. ABBOTT BD, BIRNBAUM LS, PRATT RM: TCDD-induced hyperplasia of the ureteral epithelium produces hydronephrosis in murine fetuses. Teratology 35:329-334, 1987
10. TADROS Y, RUIZ-DEYA G, et al: In vivo proteomic analysis of cytokine expression in laser capture-microdissected urothelial cells of obstructed ureteropelvic junction procured by laparoscopic dismembered pyeloplasty. J Endourol 17:333-336, 2003
11. DE BOER WI, REBEL JM, THIJSSEN CD, et al: Hyperplasia of epithelium adjacent to transitional cell carcinoma can be induced by growth factors through paracrine pathways. Virchows Arch 425:439-444, 1994
12. HAYDAY A, VINEY JL: The ins and outs of body surface immunology. Science 290:97-100, 2000
13. HEDGES S, SVENSSON M, SVANBORG C: Interleukin-6 response of epithelial cell lines to bacterial stimulation in vitro. Infect Immun 60:1295-1301, 1992
14. CROMWELL O, HAMID Q, CORRIGAN CJ, et al: Expression and generation of interleukin-8, IL-6 and granulocyte-macrophage colony-stimulating factor by bronchial epithelial cells and enhancement by IL-I beta and tumour necrosis factor-alpha. Immunology 77:330-337, 1992
15. STADNYK AW: Intestinal epithelial cells as a source of inflammatory cytokines and chemokines. Can J Gastroenterol 16:241-246, 2002
16. DAVIES DE: The bronchial epithelium: Translating gene and environment interactions in asthma. Curr Opin Allergy Clin Immunol 1:47-50, 2001
17. FERNBACH SK, MAIZELS M, CONWAY JJ: Ultrasound grading of hydronephrosis: Introduction to the system used by the Society for Fetal Urology. Pediatr Radial 23:478-480, 1993
18. CONWAY JJ: "Well-tempered" diuresis renography: Its historical development, physiological and technical pitfalls, and standardized technique protocol. Semin Nucl Med 22:74-84, 1992
19. CHIOU YY, CHIU NT, WANG ST, et al: Factors association with the outcomes of children with unilateral ureteropelvic junction obstruction. J Urol 171:397-402, 2004
20. MATSUBARA S, HIRAI S: Influence of anti-androgens on the anterior horn cells of rat spinal cord: Morphometric and in-situ hybridization studies. J Neurol Sci 161:10-15, 1998
21. CEOL M, FORINO M. GAMBARO G, et al: Quantitation of TGF-beta1 mRNA in porcine mesangial cells by comparative kinetic RT/PCR: Comparison with ribonuclease protection assay and in situ hybridization. J Clin Lab Anal 15:215-222, 2001
22. McBRIDE JT: Quantitative immunocytochemistry, in Image Analysis in Histology: Conventional and Confocal Microscopy, edited by Wootton R, Springall DR, Polak JM, New York, Cambridge University Press, 1995, pp 339-355
23. FORSSMANN U, UGUCCIONI M. LOETSCHER P, et al: Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes. J Exp Med 185:2171-2176, 1997
24. BARTOLI FA, PARADIES G, LEGGIO A, et al: Urothelium damage as the primary cause of ureteropelvic junction obstruction: A new hypothesis. Urol Res 24:9-13, 1996
25. KILICLI-CAMUR N, KILICASLAN I, GULLUOGLU MG, et al: Impact of p53 and Ki-67 in predicting recurrence and progression of superficial (pTa and pT1) urothelial cell carcinomas of urinary bladder. Pathol Int 52:463-469, 2002
26. DAWSON PA, FILIPE MI: An ultrastructural and histochemical study of the mucous membrane adjacent to and remote from carcinoma of the colon. Cancer 37:2388-2398, 1976
27. MANETTI R, PARRONCHI P, GIUDIZI MG, et al: Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 177:1199-1204, 1993
28. MOSMANN TR, CHERWINSKI H, BOND MW, et al; Two types of murine helper T cell clone: I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136:2348-2357, 1986
29. SEWELL WA, MU HH: Dissociation of production of interleukin-4 and interleukin-5. Immunol Cell Biol 74:274-277, 1996
30. NAORA H, ALTIN JG, YOUNG IG: TCR-dependent and -independent signaling mechanisms differentially regulate lymphokine gene expression in the murine T helper clone D10.G4.1. J Immunol 152:5691-5702, 1994
31. SHALIT M, SEKHSARIA S, MALECH HL: Modulation of growth and differentiation of eosinophils from human peripheral blood CD34+ cells by 1L5 and other growth factors. Cell Immunol 160:50-57, 1995
32. WARDLAW AJ, MOQBEL R, KAY AB: Eosinophils: Biology and role in disease. Adv Immunol 60:151-266, 1995
33. LACY P, MOQBEL R: Immune effector functions of eosinophils in allergic airway inflammation. Curr Opin Allergy Clin Immunol 1:79-84, 2001
34. GUTIERREZ-RAMOS JC, LLOYD C, GONZALO JA: Eotaxin: From an eosinophilic chemokine to a major regulator of allergic reactions. Immunol Today 20:500-504, 1999
35. TENSCHER K, METZNER B, SCHOPF E, et al: Recombinant human eotaxin induces oxygen radical production, Ca(2+)-mobilization, actin reorganization, and CD11b upregulation in human eosinophils via a pertussis toxin-sensitive heterotrimeric guanine nucleotide-binding protein. Blood 88:3195-3199, 1996
36. CHUANG KP, TSAI WS, WANG YJ, SHIEH CC: Superoxide activates very late antigen-4 on an eosinophil cell line and increases cellular binding to vascular cell adhesion molecule-1. Eur J Immunol 33:645-655, 2003
37. OCHI H, HIRANI WM, YUAN Q, et al: T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro. J Exp Med 190:267-280, 1999
38. GALLI SJ: New concepts about the mast cell. N Engl J Med 328:257-265, 1993